Eisai
4523.T
#2309
Rank
A$11.70 B
Marketcap
A$41.52
Share price
-2.25%
Change (1 day)
-6.61%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: A$0.73 Billion

According to Eisai's latest financial reports the company's current earnings are A$5.06 Billion. In 2023 the company made an earning of A$0.73 Billion, an increase over its 2022 earnings that were of -A$31.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023A$0.73 B-2404.04%
2022-A$31.81 Million-103.6%
2021A$0.88 B-39.81%
2020A$1.46 B7.44%
2019A$1.36 B17.22%
2018A$1.16 B86.16%
2017A$0.62 B-23.52%
2016A$0.81 B26.97%
2015A$0.64 B22.3%
2014A$0.52 B-46.07%
2013A$0.97 B-21.85%
2012A$1.25 B-20.59%
2011A$1.57 B-8.91%
2010A$1.73 B19.21%
2009A$1.45 B